Compugen Announces Appointment of Alberto Sessa as Chief Financial Officer

/PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today...

Related Keywords

Jerusalem ,Israel General ,Israel ,Tel Aviv ,Alberto Sessa ,Yvonne Naughton ,Amdocs ,Corporate Communications Compugen Ltd ,Stock Exchange ,Compugen ,Nasdaq ,Master Of Business Administration ,Astrazeneca ,Hebrew University Of Jerusalem ,Worldwide Group ,Prnewswire Compugen Ltd ,Chief Financial Officer ,Anat Cohen Dayag ,Chief Executive Officer ,Business Administration ,Hebrew University ,South San Francisco ,Investor Relations ,Corporate Communications Compugen ,Compugen Ltd ,